Current Investment Opportunities

All our investments have a lead investor who invests at the same share price, and receives the same share class as you. We don't charge a membership fee, nor do we take a percentage of any profits. There is also EIS and SEIS tax relief available on most opportunities.


 

25 DAYS TO GO
EIS
Orthogem is focused on the discovery and development of advanced synthetic bone graft. Lead investor Oxford Technology Management for over 30 years has specialised in making and managing investments in startups and early stage technology-based businesses.
N E W
Lead Investor
CAPITAL INVESTED
£284,934
 
  57%
EQUITY OFFERED
30.83%
CAPITAL REQUIRED
£500,000
PRE-MONEY VALUATION
£1,121,539
 
Image Scan
3DX-RAY Ltd is a global market and technology leader in line-scan x-ray imaging systems for the security and industrial inspection markets.
Hardware
Lead Investor
CAPITAL INVESTED
£1
 
  0%
EQUITY OFFERED
10.00%
CAPITAL REQUIRED
£1,000,000
PRE-MONEY VALUATION
£9,000,000
 
OVERFUNDING 4 DAYS TO GO
EIS
Cipher Surgical offers an innovative method of maintaining vision during a laparoscopic procedure. The round is led by two investors; Federico Forcolini heads a Family Office and Martyn Smith is an experienced C-level executive.
Health
Lead Investor
CAPITAL INVESTED
£982,050
 
  116%
EQUITY OFFERED
7.81%
CAPITAL REQUIRED
£844,950
PRE-MONEY VALUATION
£9,973,500
 
OVERFUNDING 4 DAYS TO GO
EIS
Small Pharma is developing an oral rapid-acting antidepressant that they believe could make a difference in the lives of those experiencing severe depression. Lead investor, Chris co-founded Horizon Discovery, which listed on the LSE in 2014.
Health
Lead Investor
CAPITAL INVESTED
£689,248
 
  115%
EQUITY OFFERED
22.93%
CAPITAL REQUIRED
£600,000
PRE-MONEY VALUATION
£2,016,639
 
OVERFUNDING 4 DAYS TO GO
EIS
The creator of smart refrigeration technology designed to avoid harmful gases and enable lower cost high-efficiency cooling appliances.
Green Technology
Lead Investor
CAPITAL INVESTED
£548,951
 
  110%
EQUITY OFFERED
13.38%
CAPITAL REQUIRED
£499,990
PRE-MONEY VALUATION
£3,237,338
 
11 DAYS TO GO
EIS
Renovare Fuels converts biodegradable waste into diesel and petrol using patented technology developed in conjunction with NASA and the US Department of Energy. Their CTO was recognised by Forbes as one of '30 under 30' in this field.
Green Technology
Lead Investor
CAPITAL INVESTED
£481,352
 
  80%
EQUITY OFFERED
8.00%
CAPITAL REQUIRED
£600,000
PRE-MONEY VALUATION
£6,900,000
 
OVERFUNDING 11 DAYS TO GO
EIS
Aeristech develop and manufacture patented electric superchargers: boosting engines, reducing fuel consumption and CO2 emissions. Ernest has invested in a portfolio of 13 companies, as well as founding and exiting his own company.
Green Technology | Hardware
Lead Investor
CAPITAL INVESTED
£387,529
 
  155%
EQUITY OFFERED
2.56%
CAPITAL REQUIRED
£250,000
PRE-MONEY VALUATION
£9,509,426
 
18 DAYS TO GO
EIS
Absynth Biologics aims to discover and develop vaccines to prevent and treat common bacterial infections. This round is lead by Alderley Park Ventures (APV), a £5M incubation fund managed by the BioCity Group.
Health | B2B – Business to Business
Lead Investor
CAPITAL INVESTED
£201,201
 
  50%
EQUITY OFFERED
10.94%
CAPITAL REQUIRED
£400,000
PRE-MONEY VALUATION
£3,255,700
 
18 DAYS TO GO
EIS
A platform where content producers can browse and order stock videos and images. Lead investor Nick Evans-Lombe helped establish Getty Communications, later Getty Images, where he was part of the team that took the company through IPO.
B2B – Business to Business
Lead Investor
CAPITAL INVESTED
£686,998
 
  92%
EQUITY OFFERED
23.15%
CAPITAL REQUIRED
£750,000
PRE-MONEY VALUATION
£2,490,150
 
25 DAYS TO GO
EIS
Squirrel aims to make it easy and intuitive to create – and stick to – a budget. Lead investor Jos Evans is a sophisticated investor with a number of successful investment exits under his belt including Bright North and Numecent.
Web & Apps
Lead Investor
CAPITAL INVESTED
£199,314
 
  50%
EQUITY OFFERED
5.99%
CAPITAL REQUIRED
£400,019
PRE-MONEY VALUATION
£6,273,335